• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Dr. Richard Rosenfeld recommends shared decision-making in treating adult sinusitis

Bioengineer by Bioengineer
September 8, 2016
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
sunny
SUNY Downstate Medical Center’s Distinguished Professor and Chair of Otolaryngology Richard M. Rosenfeld, MD

Brooklyn, NY – In an article in the New England Journal of Medicine, SUNY Downstate Medical Center’s Distinguished Professor and Chair of Otolaryngology Richard M. Rosenfeld, MD, MPH, recommends a process of shared decision-making between physicians and patients in the treatment of adult sinusitis.

The article is a pragmatic, evidence-based approach to best practice in treating sinus infections in adults. Notable aspects are (a) a diagnostic flowchart for physician use that facilitates accurate diagnosis of bacterial sinus infections using only history and symptoms, and (b) an emphasis on symptomatic treatment of sinus infections, minimizing antibiotic use, even when the sinusitis is likely caused by bacteria.

In the article, Dr. Rosenfeld notes that acute sinusitis is classified according to presumed cause as either acute bacterial sinusitis or acute viral sinusitis. Although up to 90% of patients with viral upper respiratory tract infections have concurrent acute viral sinusitis, only 0.5 to 2.0% have sinusitis that progresses to acute bacterial sinusitis.

Nonetheless, antibiotics are prescribed for 84 to 91% of patients with acute sinusitis that is diagnosed in emergency departments and outpatient settings, a discrepancy that relates, in part, to patient expectations regarding antibiotic therapy and to an inconsistency between clinical guidelines and antibiotic-prescribing patterns.

Dr. Rosenfeld recommends that physicians should engage in shared decision-making with patients to determine whether to prescribe an immediate course of antibiotics or if a period of “watchful waiting” should be pursued. If watchful waiting is chosen, the patient may be given a “safety-net” or “wait-and-see” prescription for an antibiotic to use if the illness worsens at any time or if the symptoms do not decrease within seven days. The patient should be advised to contact the physician if the symptoms have not decreased by that time or if symptoms worsen at any point.

The article is entitled “Acute Sinusitis in Adults”; N Engl J Med 2016;375:962-70. DOI: 10.1056/NEJMcp1601749.

###

SUNY Downstate Medical Center, founded in 1860, was the first medical school in the United States to bring teaching out of the lecture hall and to the patient’s bedside. A center of innovation and excellence in research and clinical service delivery, SUNY Downstate Medical Center comprises a College of Medicine, College of Nursing, College of Health Related Professions, a School of Graduate Studies, School of Public Health, University Hospital of Brooklyn, and a multifaceted biotechnology initiative including the Downstate Biotechnology Incubator and BioBAT for early-stage and more mature companies, respectively.

SUNY Downstate ranks twelfth nationally in the number of alumni who are on the faculty of American medical schools. More physicians practicing in New York City have graduated from SUNY Downstate than from any other medical school.

Media Contact

Ronald Najman
ron.najman@downstate.edu
718-270-2696

http://www.downstate.edu

The post Dr. Richard Rosenfeld recommends shared decision-making in treating adult sinusitis appeared first on Scienmag.

Share13Tweet8Share2ShareShareShare2

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026
Please login to join discussion

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.